Prevention of venous thromboembolism in hospitalized acutely ill medical patients: focus on the clinical utility of (low-dose) fondaparinux

References

• Geerts WH Bergqvist D Pineo GF Prevention of Venous Thromboembolism: American College of Chest Physicians Evidence Based Clinical Practice Guidelines (8th edition) Chest 2008 133 381 453
   PubMed Web of Science ®Google Scholar
• Kahn SR Lim W Dunn AS Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (9th edition) Chest 2012 141 Suppl 2 195S 226S
   Web of Science ®Google Scholar
• Dentali F Douketis JD Gianni M Lim W Crowther MA Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients Ann Intern Med 2007 146 278 288 17310052
   PubMed Web of Science ®Google Scholar
• Wein L Wein S Haas SJ Shaw J Krum H Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials Arch Intern Med 2007 167 1476 1486 17646601
   PubMed Web of Science ®Google Scholar
• Amin AN Lin J Thompson S Wiederkehr D Real-world rates of in-hospital and post discharge deep-vein thrombosis and pulmonary embolism in at-risk medical patients in the United States Clin Appl Thromb Hemost 2011 17 611 619 21593021
   PubMed Web of Science ®Google Scholar
• Francis CW Prophylaxis for thromboembolism in hospitalized medical patients N Engl J Med 2007 356 1438 1444 17409325
   PubMed Web of Science ®Google Scholar
• Simmons AV Sheppard MA Cox AF Deep venous thrombosis after myocardial infarction: predisposing factors Br Heart J 1973 35 623 625 4123229
   PubMedGoogle Scholar
• Emerson PA Marks P Preventing thromboembolism after myocar-dial infarction: effect of low-dose heparin or smoking BMJ 1977 1 18 20 831965
   PubMed Web of Science ®Google Scholar
• Kelly J Rudd A Lewis RR Coshall C Moody A Hunt BJ Venous thromboembolism after acute ischemic stroke: a prospective study using magnetic resonance direct thrombus imaging Stroke 2004 35 2320 2325 15322298
   PubMed Web of Science ®Google Scholar
• Sherman DG Albers GW Bladin C The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison Lancet 2007 369 1347 1355 17448820
   PubMed Web of Science ®Google Scholar
• Alikhan R Cohen AT Combe S Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study Arch Intern Med 2004 164 963 968 15136304
   PubMed Web of Science ®Google Scholar
• Grainge MJ West J Card TR Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study Lancet 2010 375 657 663 20149425
   PubMed Web of Science ®Google Scholar
• Matta F Singala R Yaekoub AY Najjar R Stein PD Risk of venous thromboembolism with rheumatoid arthritis Thromb Haemost 2009 101 134 138 19132199
   PubMed Web of Science ®Google Scholar
• Samama MM Combe S Conard J Horellou M-H Risk assessment models for thromboprophylaxis of medical patients Thromb Res 2012 129 127 132 22047755
   PubMed Web of Science ®Google Scholar
• Barbar S Noventa F Rossetto V A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score J Thromb Haemost 2010 8 2450 2457 20738765
   PubMed Web of Science ®Google Scholar
• Hill J Treasure T Reducing the risk of venous thromboembolism in patients admitted to hospital: summary of NICE guidance BMJ 2010 340 c95 20106897
   PubMed Web of Science ®Google Scholar
• Dobromirski M Cohen M How I manage venous thromboembolism risk in hospitalized medical patients Blood 2012 120 1562 1569 22705598
   PubMed Web of Science ®Google Scholar
• Lederle FA Zylla D MacDonald R Wilt TJ Venous thromboembolism prophylaxis in hospitalized medical patients and those with stroke: a background review for an American College of Physicians clinical practice guideline Ann Intern Med 2011 155 602 615 22041949
   PubMed Web of Science ®Google Scholar
• Samama MM Cohen AT Darmon JY A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group N Engl J Med 1999 341 793 800 10477777
   PubMed Web of Science ®Google Scholar
• Leizorovicz A Cohen AT Turpie AGG Olsson CG Vaitkus PT Goldhaber SZ Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients Circulation 2004 110 874 879 15289368
   PubMed Web of Science ®Google Scholar
• Cohen AT Davidson BL Gallus AS Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial BMJ 2006 332 325 329 16439370
   PubMed Web of Science ®Google Scholar
• Goldhaber SZ Leizorovicz A Kakkar AK Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients N Engl J Med 2011 365 2167 2177 22077144
   PubMed Web of Science ®Google Scholar
• Cohen AT Spiro TE Büller HR Rivaroxaban for thromboprophylaxis in acutely ill medical patients N Engl J Med 2013 368 513 223 23388003
   PubMed Web of Science ®Google Scholar
• Albertsen IE Larsen TB Rasmussen LH Overvad TF Lip GYH Prevention of venous thromboembolism with new oral anticoagulants versus standard pharmacological treatment in acute medically ill patients: a systematic review and meta-analysis Drugs 2012 72 1755 1764 22876779
   PubMed Web of Science ®Google Scholar
• Eikelboom JW Quinlan DJ O’Donnell M Major bleeding, mortality, and efficacy of fondaparinux in venous thromboembolism prevention trials Circulation 2009 120 2006 2011 19884469
   PubMed Web of Science ®Google Scholar
• Eikelboom JW Effect of fondaparinux 2.5 mg once daily on mortality: a meta-analysis of phase III randomized trials of venous thromboembolism prevention Eur Heart J Suppl 2008 10 C8 C13
   Web of Science ®Google Scholar
• Spencer FA Lessard D Emery C Reed G Goldberg RJ Venous thromboembolism in the outpatient setting Arch Intern Med 2007 167 1471 1475 17646600
   PubMed Web of Science ®Google Scholar
• Decousous H Tapson VF Bergmann JF Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators Chest 2011 139 69 79 20453069
   PubMed Web of Science ®Google Scholar
• Fanikos J Rao A Seger AC Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge Am J Med 2011 124 1143 1150 22114828
   PubMed Web of Science ®Google Scholar
• Hull RD Schellong SM Tapson VF Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial Ann Intern Med 2010 153 8 18 20621900
   PubMed Web of Science ®Google Scholar
• Spyropoulos AC Fisher M Mahan C Incidence and risk factors for post-discharge VTE among medically ill patients hospitalized in the United States: 2005–2009. J Thromb Haemost Conference: 23rd Congress of the International Society on Thrombosis and Haemostasis 57th Annual SSC Meeting Kyoto, Japan 9; 2011 25
   Google Scholar
• Mahan C Klaskala W Fisher M Risk factors for post-discharge bleeding in US medically ill patients at risk of venous thromboembolism (VTE). J Thromb Haemost Conference: 23rd Congress of the International Society on Thrombosis and Haemostasis 57th Annual SSC Meeting Kyoto Japan 9; 2011 410
   Google Scholar
• Cohen AT Tapson VF Bergmann J-F Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study Lancet 2008 371 387 394 18242412
   PubMed Web of Science ®Google Scholar
• Bhowmik SS Biswas S Kharbanda M Chatterjee TK Nandy S Utilization of DVT prophylaxis in non ICU hospitalized patients Asian Pacific J Trop Dis 2012 2 Suppl 2 S707 S711
   Google Scholar
• Pendergraft T Liu X Edelsberg J Prophylaxis against venous thromboembolism in hospitalized medically ill patients Circ Cardiovasc Qual Outcomes 2013 6 75 82 23300270
   PubMed Web of Science ®Google Scholar
• Baser O Sengupta N Dysinger A Wang L Thromboembolism prophylaxis in medical inpatients: effect on outcomes and costs Am J Manag Care 2012 18 294 302 22774997
   PubMed Web of Science ®Google Scholar
• Khoury H Welner S Kubin M Folkerts K Haas S Disease burden and unmet needs for prevention of venous thromboembolism in medically ill patients in Europe show underutilisation of preventive therapies Thromb Haemost 2011 106 600 608 21833448
   PubMed Web of Science ®Google Scholar
• Mokhtari M Salameh P Kouchek M Kashani BS Taher A Waked M The AVAIL ME Extension: a multinational Middle Eastern survey of venous thromboembolism risk and prophylaxis J Thromb Haemost 2011 9 1340 1349 21605327
   PubMed Web of Science ®Google Scholar
• Bhalla R Berger MA Reissman SH Improving hospital venous thromboembolism prophylaxis with electronic decision support J Hosp Med 2013 8 115 120 23184857
   PubMed Web of Science ®Google Scholar
• Piazza G Rosenbaum EJ Pendergast W Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patients Circulation 2009 119 2196 2201 19364975
   PubMed Web of Science ®Google Scholar
• Kucher N Koo S Quiroz R Electronic alerts to prevent venous thromboembolism among hospitalized patients N Engl J Med 2005 352 969 977 15758007
   PubMed Web of Science ®Google Scholar
• Lloyd NS Douketis JD Moinuddin I Lim W Crowther MA Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients: a systematic review and meta-analysis J Thromb Haemost 2008 6 405 414 18031292
   PubMed Web of Science ®Google Scholar
• Dentali F Riva N Gianni M Prevalence of renal failure and use of thromboembolic prophylaxis among medical inpatients at increased risk of venous thromboembolic events Thromb Res 2008 123 67 71 18328541
   PubMed Web of Science ®Google Scholar
• Ageno W Riva N Noris P Safety and efficacy of low-dose fondaparinux (1.5 mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: the FONDAIR study J Thromb Haemost 2012 10 2291 2297
   Web of Science ®Google Scholar
• Francis CW Prevention of venous thromboembolism in hospitalized patients with cancer J Clin Oncol 2009 27 4874 4880 19704060
   PubMed Web of Science ®Google Scholar
• Farge D Debourdeau P Beckers M International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer J Thromb Haemost 2013 11 56 70 23217107
   PubMed Web of Science ®Google Scholar
• Chan CM Shorr AF Venous thromboembolic disease in the intensive care unit Semin Respir Crit Care Med 2010 31 39 46 20101546
   PubMed Web of Science ®Google Scholar
• Cook DJ Crowther MA Thromboprophylaxis in the intensive care unit: focus on medical-surgical patients Crit Care Med 2010 38 Suppl S76 S82 20083918
   PubMed Web of Science ®Google Scholar
• Cook D Douketis J Meade M Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors Crit Care 2008 12 R32 18315876
   PubMed Web of Science ®Google Scholar
• Cumbo-Nacheli G Samavati L Guzman JA Bioavailability of fondaparinux to critically ill patients J Crit Care 2011 26 342 346 20889286
   PubMed Web of Science ®Google Scholar
• The PROTECT Investigators for the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Society Clinical Trials Group Dalteparin versus unfractionated heparin in critically ill patients N Engl J Med 2011 364 1305 1314 21417952
   PubMed Web of Science ®Google Scholar
• Warkentin TE Pai M Sheppard JI Schulman S Spyropoulos AC Eikelboom JW Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series J Thromb Haemost 2011 9 2389 2396 21883878
   PubMed Web of Science ®Google Scholar
• Linkins L-A Dans AL Moores LK Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-based Clinical Practice Guidelines Chest 2012 141 e495S e530S 22315270
   PubMed Web of Science ®Google Scholar
• Kelton JG Arnold DM Bates SM Nonheparin anticoagulants for heparin-induced thrombocytopenia N Engl J Med 2013 368 737 744 23425166
   PubMed Web of Science ®Google Scholar